
Childhood ADHD stimulant use may lower later psychosis risk, study finds
A Finnish study of nearly 4,000 children with ADHD found that sustained methylphenidate treatment (Ritalin/Concerta) before age 13 for about 3–4 years did not increase—and may reduce—the risk of developing psychotic disorders later; the overall ADHD–psychosis link may reflect shared genetics rather than medication. Experts caution that findings may not apply to older adolescents and that amphetamine-based treatments could carry higher risk, highlighting the need for more research on dosing, timing, and long-term effects.

